PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of copKargerHomeAlertsResourcesThis articleJournal Home
 
Case Rep Ophthalmol. 2017 May-Aug; 8(2): 390–395.
Published online 2017 July 24. doi:  10.1159/000478720
PMCID: PMC5597918

Ruptured Retinal Arterial Macroaneurysm Secondary to Toxoplasmic Kyrieleis Arteriolitis: A Case Report

Abstract

Purpose

The aim of this report was to describe multimodal ocular imaging findings in a patient who presented with a ruptured retinal arterial macroaneurysm (RAM) associated with toxoplasmic Kyrieleis arteriolitis.

Methods

We report the case of a 64-year-old man with a history of systemic hypertension and dense amblyopia of the left eye who presented with decreased vision and new floaters in the left eye. Color fundus photography, spectral-domain optical coherence tomography, fluorescein angiography, and indocyanine green angiography were used as diagnostic imaging tools.

Results

No signs of hypertensive retinopathy were noted in the right eye. Multiple chorioretinal scars characteristic of previous toxoplasmosis were revealed in the left eye, with one covering most of the macula. Periarterial plaques or Kyrieleis arteriolitis were observed in retinal arteries surrounding the toxoplasmic retinal scars. Multiple RAMs were observed in these vessels, one of which was acutely ruptured. A perivenular plaque associated with a chronic branch retinal vein occlusion (BRVO) was noted along the same arcade at the arteriovenous crossing.

Conclusion

RAM formation and BRVO can present as possible long-term complications of toxoplasmic Kyrieleis arteriolitis. This is the first reported case demonstrating an association between toxoplasmic Kyrieleis arteriolitis and RAM formation.

Keywords: Ocular toxoplasmosis, Retinal arterial macroaneurysm, Kyrieleis arteriolitis

Introduction

Toxoplasmic retinitis has been reported to cause periarterial plaques, also known as Kyrieleis arteriolitis [1]. There have been no reported cases of retinal arterial macroaneurysm (RAM) associated with Kyrieleis arteriolitis. In this case report, we present a patient with a ruptured RAM in the setting of Kyrieleis arteriolitis.

Case Report

A 64-year-old male presented with a 4-day history of new floaters and decreased vision in the left eye. His past medical history was significant for systemic hypertension and dense amblyopia of the left eye, likely due to toxoplasmic macular scarring. On physical exam, visual acuity was 20/20 in the right eye and 20/300 in the left eye. Intraocular pressures were normal. Pupils were normal with no afferent pupillary defect. Extraocular movements were full with a large-angle exotropia of the left eye. On fundus exam, the right eye had a normal fundus with no signs of hypertensive retinopathy (Fig. (Fig.1a).1a). Fig. Fig.1b1b is a color fundus photograph of the left eye, which revealed a large variably pigmented chorioretinal lesion covering almost the entire macula, consistent with an inactive toxoplasmic scar. Multilevel retinal hemorrhage consistent with RAM can be observed. There was moderate vitreous hemorrhage, mostly inferiorly settled. Preretinal hemorrhage superior to the optic nerve and preretinal, retinal, and subretinal hemorrhages adjacent to the macular scar were noted. A second small chorioretinal scar adjacent to the superotemporal arcade was observed on the color fundus photograph. The superotemporal arcade vessels showed significant attenuation with periarterial plaques, consistent with old toxoplasmic Kyrieleis arteriolitis (Fig. (Fig.1b).1b). Both fundus fluorescein angiography (FA) and indocyanine green angiography (ICGA) (Fig. 2a, b) of the right eye showed normal retinochoroidal vasculature. Figure Figure3a3a illustrates the late phase of the FA of the left eye, which demonstrated a homogeneously hypofluorescent masking lesion contiguous to the macular scar, congruous with preretinal hemorrhage. Three hyperfluorescent RAMs were detected in the vessels feeding the retinal scars, with a prominent one located at the center of the masking lesion, which is most likely the site of rupture. Besides the 2 toxoplasmic retinal scars seen on fundus photography, FA revealed a third large chorioretinal hypofluorescent scar located in the superotemporal mid-periphery. Both large retinal scars were hypofluorescent with hyperfluorescent margins. In addition, there were multiple microaneurysms located superior to the macular scar and along the superotemporal arcade, as well as retinal capillary nonperfusion and retinal collaterals adjacent to the mid-peripheral chorioretinal scar, likely resulted from chronic branch retinal venous occlusion at the arteriovenous crossing (Fig. (Fig.3a).3a). On ICGA, as demonstrated in Figure Figure3b,3b, vessels around the chorioretinal scars were attenuated, with no evidence of leaking or active vasculitis, and the same RAMs seen on FA were also evident. As shown in Figure 4a–c, the spectral-domain optical coherence tomography revealed hyperreflective preretinal and subretinal lesions adjacent to a hyperreflective atrophied macular scar, consistent with preretinal and subretinal hemorrhages.

Fig. 1
a Color fundus photograph of the right eye shows a normal fundus. b Color fundus photograph of the left eye demonstrates retinal multilevel hemorrhage adjacent to a variably pigmented macular toxoplasmic scar. Black arrow, Kyrieleis arteriolitis with ...
Fig. 2
Fundus fluorescein angiography (a) and indocyanine green angiography (b) of the right eye show normal retinal and choroidal vessels.
Fig. 3
a Fundus fluorescein angiography of the left eye illustrates 3 hypofluorescent chorioretinal scars with hyperfluorescent margins in the macula and along the superotemporal arcade and superotemporal mid-periphery, respectively. b Indocyanine green angiography ...
Fig. 4
a Spectral-domain optical coherence tomography (SD OCT) of the retina with a hyperreflective preretinal hemorrhage over the site of a ruptured retinal arterial macroaneurysm. b SD OCT of the retina with a hyperreflective subretinal hemorrhage adjacent ...

Considering that this patient did not have an active toxoplasmosis, active vasculitis, or significant macular edema and the history of dense amblyopia due to the macular scarring, we decided to manage his ruptured RAM expectantly. The patient's symptoms remained stable with gradual resolution of the vitreous hemorrhage at the 1-week return visit. His visual acuity returned to baseline within several months. Unfortunately, the patient was lost to follow-up afterwards.

Discussion

Ocular toxoplasmosis is a common cause of significant visual loss in the youth population [2]. Congenital ocular toxoplasmosis is more likely than acquired infection to be bilateral [2]. Acute acquired ocular toxoplasmosis can present at any age and has a predilection for presenting with larger lesions [3]. It is known that most RAMs are associated with aging of the vessel walls and cardiovascular diseases, such as systemic hypertension, arterial emboli, and arteriosclerosis [4, 5]. Toxoplasmosis retinitis has been reported to cause periarterial plaques, also known as Kyrieleis arteriolitis (Fig. (Fig.1b),1b), which could induce arterial emboli [1]. Therefore, we propose that the mechanism of multiple RAM formation in our patient was likely a sequela of retinal arterial emboli triggered by toxoplasma vasculitis. In addition, this process could have been aggravated by the patient's history of hypertension. However, fundus examination, FA, and ICGA of the fellow eye did not reveal signs of hypertensive retinopathy (Fig. (Fig.1a,1a, Fig. 2a, b). Therefore, the extent to which systemic hypertension contributed to the formation of the macroaneurysm is limited, further suggesting that old toxoplasmic vasculitis played a role. In addition, branch retinal vein occlusion (BRVO) has been reported to be associated with retinal toxoplasmosis [6, 7]. A chronic BRVO along with its complications – formation of microaneurysms, retinal capillary nonperfusion, and retinal collaterals – is also present in our patient (Fig. (Fig.3a3a).

Traditionally, when toxoplasmosis is active and involving the macula, triple therapy (pyrimethamine, sulfadiazine, and prednisone) has been used [8]. This patient did not have active disease, so triple therapy was not considered. Visual outcome for ruptured RAM is favorable [9, 10]. Treatment options for ruptured RAM include observation, focal laser coagulation, and intravitreal bevacizumab for secondary macular edema [9, 10, 11, 12, 13, 14]. Observation is sufficient in some uncomplicated cases, as aneurysmal hemorrhaging usually spontaneously undergoes sclerosis and occlusion as part of its natural course [10]. Conventional laser photocoagulation of the macroaneurysm has been the most commonly utilized treatment for symptomatic RAM; however, it may carry the risk of an increased rate of arterial occlusion, capillary dropout, subretinal fibrosis, enlargement of laser scar, and choroidal neovascularization compared to nontreatment [10, 11, 12, 13, 14]. A recent clinical trial suggests that subthreshold laser treatment may carry fewer risks [12]. Intravitreal bevacizumab has been shown to be an effective treatment for improving visual acuity in patients with complicated RAM involving the fovea [14].

Conclusion

We conclude that RAM formation and chronic BRVO could present as long-term sequelae of vasculitis in the context of toxoplasmic retinitis. To our knowledge, this is the first case in the literature describing an association between Kyrieleis arteriolitis and RAM formation.

Statement of Ethics

The patient discussed in this case report provided written informed consent; authorization for publication was provided.

Disclosure Statement

The authors declare no conflicts of interest.

References

1. Agarwal A. Infectious diseases of the retina and choroid. In: Agarwal A, editor. Gass’ Atlas of Macular Diseases. ed 5. Philadelphia, PA: Saunders; 2013. pp. 850–854.
2. Atmaca LS, Simsek T, Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J of Ophthalmol. 2004;48:386–391. [PubMed]
3. Delair E, Latkany P, Noble AG, Rabiah P, McLeod R, Brézin A. Clinical manifestations of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:91–102. [PubMed]
4. Panton RW, Goldberg MF, Farber MD. Retinal arterial macroaneurysms: risk factors and natural history. Br J Ophthalmol. 1990;74:595. [PMC free article] [PubMed]
5. Chew EY, Murphy R. Acquired retinal macroaneurysms. In: Ryan SJ, editor. Retina. ed 5. London: Saunders/Elsevier; 2013. pp. 1026–1028.
6. Kouros P, Gerding H. Retinochoroiditis toxoplasmotica initially presenting as branch retinal vein occlusion. Klin Monatsbl Augenheilkd. 2015;232:573–575. [PubMed]
7. Aggio FB, Novelli FJ, Rosa EL, Nobrega MJ. Combined branch retinal vein and artery occlusion in toxoplasmosis. Arq Bras Oftalmol. 2016;79:189–191. [PubMed]
8. Soheilian M, Ramezani A, Azimzadeh A, Azimzadeh A, Mehdi Sadoughi M, Dehghan MH, Shahghadami R, Yaseri M, Peyman GA. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology. 2011;118:134–141. [PubMed]
9. Koinzer S, Heckmann J, Tode J, Roider J. Long-term, therapy-related visual outcome of 49 cases with retinal arterial macroaneurysm: a case series and literature review. Br J Ophthalmol. 2015;99:1345–1353. [PubMed]
10. Brown DM, Sobol WM, Folk JC, Weingeist TA. Retinal arteriolar macroaneurysms: long-term visual outcome. Br J Ophthalmol. 1994;78:534–538. [PMC free article] [PubMed]
11. Panton RW, Goldberg MF, Farber MD. Retinal arterial macroaneurysms: risk factors and natural history. Br J Ophthalmol. 1990;74:595. [PMC free article] [PubMed]
12. Battaglia Parodi M, Iacono P, Pierro L, Papayannis A, Kontadakis S, Bandello FM. Subthreshold laser treatment versus laser treatment for symptomatic retinal arterial macroaneurysms. Invest Ophthalmol Vis Sci. 2012;53:1783–1786. [PubMed]
13. Pieramici DJ, Risard SM, Rabena MD. Retinal neovascularization associated with a retinal arterial macroaneurysm. Retin Cases Brief Rep. 2009;3:415. [PubMed]
14. Pichi F, Morara M, Torrazza C, Manzi G, Alkabes M, Balducci N, Vitale L, Lembo A, Ciardella A, Nucci P. Intravitreal bevacizumab for macular complications from retinal arterial macroaneurysms. Am J Ophthalmol. 2013;155:287–294. [PubMed]

Articles from Case Reports in Ophthalmology are provided here courtesy of Karger Publishers